Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: A follow-up study in PNET 3 trial survivors - On behalf of the CCLG (formerly UKCCSG)

Journal of Clinical Oncology

Volumn 25, Issue 27, 2007, Pages 4239-4245

  Bull, Kim S ^a   Spoudeas, Helen A ^a   Yadegarfar, Ghasem ^a   Kennedy, Colin R ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR; BODY BUILD; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MALE; MEDULLOBLASTOMA; MULTICENTER STUDY; PATIENT EDUCATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PUBERTY; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL SUPPORT; UNITED KINGDOM; ADULT; BRAIN TUMOR; SKULL IRRADIATION; SPINAL CORD TUMOR; SURVIVOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS; CRANIAL IRRADIATION; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MEDULLOBLASTOMA; QUALITY OF LIFE; SPINAL NEOPLASMS; SURVIVORS; TREATMENT OUTCOME;

EID: 34948897496     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.7684     Document Type: Article

References (40)

1. Tait DM, Thornton-Jones H, Bloom HJG, et al: Adjuvant chemotherapy for medulloblastoma: The first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP). Eur J Cancer 26:464-469, 1990
2. Bailey CC, Gnekow A, Wellek S, et al: Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO): SIOP II. Med Ped Oncol 25:166-178, 1995
3. Taylor RE, Bailey CC, Robinson K, et al: Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiation Oncology Bio Phys 58:1184-1193, 2004
4. Evans AE, Jenkin RD, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomised trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 72:572-582, 1990
5. Bouffet E, Gentet JC, Doz F, et al: Metastatic medulloblastoma: The experience of the French Cooperative M7 Group. Eur J Cancer 30a:1478-1483, 1994
6. Packer RJ, Sutton LN, Goldwein JW, et al: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433-440, 1991
7. Pezzotta S, Cordero di Montezemolo L, Knerich R, et al: CNS-85 trial: A cooperative pediatric CNS tumor study - Results of treatment of medulloblastoma patients. Childs Nerv Syst 12:87-96, 1996
8. Mulhern RK, Kepner JL, Thomas PR, et al: Neuropsychological functioning of survivors of childhood medulloblastoma randomised to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J Clin Oncol 16:1723-1728, 1998
9. Ris MD, Packer R, Goldwein J, et al: Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Study Group study. J Clin Oncol 19:3470-3476, 2001
10. Grill J, Viguier D, Kieffer V, et al: Critical risk factors for intellectual impairment in children with posterior fossa tumors: The role of cerebellar damage. J Neurosurg 101:152-158, 2004
11. Steinlin M, Imfeld S, Zulauf P, et al: Neuropsychologcial long-term sequelae after posterior fossa tumour resection during childhood. Brain 126:1998-2008, 2003
12. Mulhern RK, Merchant TE, Gajjar A, et al: Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399-408, 2004
13. Palmer SL, Goloubeva O, Reddick JO, et al: Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 19:2302-2308, 2001
14. Mulhern RK, Palmer SL, Merchant TE, et al: Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511-5519, 2005
15. Rutkowski S, Bode U, Deinlein F, et al: Treatment of early childhood medulloblastoma by chemotherapy alone. N Engl J Med 352:978-986, 2005
16. Spoudeas HA, Hindmarsh PC, Matthews DRM, et al: Evolution of growth hormone (GH) neurosecretory disturbance after cranial irradiation for childhood brain tumours: A prospective study. J Endocrinol 150:329-342, 1996
17. Livesey EA, Brook CGD: Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child 63:495-500, 1988
18. Livesey EA, Brook CGD: Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 64:593-595, 1989
19. Olshan JS, Gubernick J, Packer RJ, et al: The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70:2013-2017, 1992
20. Feeny D, Furlong W, Barr RD, et al: A comprehensive multi-attribute system for classifying health status of survivors of childhood cancer. J Clin Oncol 10:923-928, 1992
21. Feeny D, Furlong W, Boyle M, et al: Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 7:490-502, 1995
22. Torrance GW, Furlong W, Feeny D, et al: Multi-attribute preference functions. Pharmacoeconomics 7:503-520, 1995
23. Torrance GW, Feeny DH, Furlong WJ, et al: Multiattribute utility function for a comprehensive status classification. Health Utilities Index Mark 2. Med Care 34:702-722, 1996
24. Goodman R: The Strengths and Difficulties Questionnaire: A research note. J Child Psychol Psychiat 38:581-586, 1994
25. Varni JW, Seid M, Rode CA: The PedsQL: Measurement model for the paediatric quality of life inventory. Med Care 37:126-139, 1999
26. Landgraf JM, Abetz L, Ware JE: The CHQ user's manual. Boston, MA Health Act, 2000
27. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
28. Osoba D, Aaronson NK, Muller M, et al: The development and psychometric validation of a brain cancer quality of life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139-150, 1996
29. Glaser A, Kennedy CR, Punt J, et al: A standardised strategy for qualitative assessment of brain tumour survivors treated within clinical trials in childhood. Int J Cancer 12:S77-S82, 1999
30. Freeman JV, Cole TJ, Chinn S, et al: Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24, 1995
31. Fayers P, Hays R (eds): Assessing Quality of Life in Clinical Trials (ed 2). Oxford, England, Oxford University Press, 2005, p 481
32. Altman DG, Machin D, Bryant TN, et al (eds): Statistics With Confidence (ed 2). London, England, BMJ Books, 2000, p 166
33. Thomson AB, Critchley HO, Wallace WH: Fertility and progeny (review). Eur J Cancer 38:1634-1644, 2002
34. Didi M, Didcock E, Davies HA, et al: High incidence of obesity in young adults after treatment of acute lymphoblastic leukaemia. J Pediatr 127:63-67, 1995
35. Reilly JJ, Ventham JC, Ralston JM, et al: Reduced energy expenditure in pre-obese children treated for acute lymphoblastic leukemia. Pediatr Res 44:557-562, 1998
36. Cole TJ, Bellizzi MC, Flegal KM, et al: Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 320:1240-1243, 2000
37. Jebb SA, Rennie KL, Cole TJ: Prevalence of overweight and obesity among young people in Great Britain. Public Health Nutr 7:461-465, 2004
38. Spoudeas HA: Growth following malignancy (review). Best Pract Res Clin Endocrinol Metab 16:561-590, 2002
39. Gleeson HK, Stoeter R, Ogilw-Stuart AL, et al: Improvement in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumours receiving GH replacement. J Clin Endocrinol Metab 66:3682-3689, 2003
40. Ogilvy-Stuart AL, Shalet SM, Gattameni HR: Thyroid function after treatment of brain tumors in children. J Pediatr 119:733-737, 1991